CPT code 81239: DMPK testing, allele characterization2026 Medicare lab fee · Clinical Laboratory Fee Schedule

Molecular analysis characterizes DMPK alleles, including expanded repeat size, in diagnostic evaluation of myotonic dystrophy type 1.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide1.7K Medicare services in 2024

Medicare pays $274.83 for 81239 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$274.83

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2020
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 8 sections
  1. Medicare lab fee
  2. What 81239 covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Related codes
  7. Billing questions
  8. Sources

What 81239 covers

This molecular genetic test characterizes DMPK alleles, including the size of an expanded allele associated with myotonic dystrophy type 1 (DM1). It is used to evaluate people with clinical features suggesting DM1 and to assess relatives when familial testing is indicated. Molecular diagnostic laboratories perform the analysis; neurologists, medical geneticists, and other clinicians may order it during diagnostic or genetic evaluation.

Report 81239 for characterization of DMPK alleles, rather than for detection of an abnormal allele alone, which is represented by 81234. Medicare pays the test only through the CLFS, using one national amount across localities and no office-versus-facility difference. The 2026 national CLFS amount is $274.83, unchanged since 2020; the code is excluded from the physician fee schedule.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 81239

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 81239. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Excluded from the physician fee schedule

The physician fee schedule lists 81239 with status X (excluded by statute), so the test itself is paid only from the CLFS.

81239 on the lab fee schedule since 2020

81239 · CLFS 2026 Q4 (current)

$274.83

Unchanged since Jan 1, 2020

Amount in each year’s latest CLFS release · bars start at $0

27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.

81239 compared with similar tests

81234DMPK testExpanded allele detection$137.00
Choose 81234 for detection of an abnormal DMPK allele. Choose 81239 when the service characterizes the alleles, including expanded size.
81243FMR1 testingAbnormal allele detection$57.04
Code 81243 concerns detection of abnormal FMR1 alleles, not characterization of DMPK alleles.
81244FMR1 testingAllele size and methylation$44.89
Code 81244 characterizes FMR1 alleles. Code 81239 characterizes DMPK alleles in the evaluation of DM1.

81239 billing questions

When should 81239 be reported instead of 81234?

Use 81239 when the DMPK service characterizes the alleles, such as determining the size of an expanded allele. Code 81234 represents detection of an abnormal DMPK allele.

What condition is associated with DMPK allele characterization?

DMPK allele characterization is used in the evaluation of myotonic dystrophy type 1 (DM1).

Is 81239 paid under the physician fee schedule?

No. Medicare pays 81239 through the CLFS; it is excluded from the physician fee schedule.

Does the CLFS amount vary by locality or setting?

No. Medicare uses one national CLFS amount for this code across localities, with no office-versus-facility difference.

How is 81239 different from FMR1 allele characterization?

Code 81239 characterizes DMPK alleles in the evaluation of DM1. Code 81244 characterizes FMR1 alleles, which are associated with a different genetic condition.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 81239PUF_CLFS_CY2026_Q4V1.csv, line 833 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 81239?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put 81239 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist